Circulating and adipose tissue gene expression of zinc-α2- glycoprotein in obesity: Its relationship with adipokine and lipolytic gene markers in subcutaneous and visceral fat

Journal of Clinical Endocrinology and Metabolism

Volumn 94, Issue 12, 2009, Pages 5062-5069

  Ceperuelo Mallafre V ^a   Naf S ^a   Escote X ^a   Caubet, E ^b   Gomez, J M ^c   Miranda, M ^a   Chacon, M R ^a   Gonzalez Clemente, J M ^d   Gallart, L ^a   Gutierrez, C ^a   Vendrell, Joan ^a  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b Surgery Service   (Spain)

^c HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^d PARC TAULÍ HOSPITAL UNIVERSITARI   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HORMONE SENSITIVE LIPASE; INSULIN; MESSENGER RNA; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; ZINC ALPHA2 GLYCOPROTEIN;

ADIPOSE TISSUE; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR RISK; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; MARKER GENE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 73249153045     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-0764     Document Type: Article

References (22)

1. Bürgi W, Schmid K 1961 Preparation and properties of Zn-a2-glycoprotein of normal human plasma. J Biol Chem 236:1066-1074
2. Tada T, Ohkubo I, Niwa M, Sasaki M, Tateyama H, Eimoto T 1991 Immunohistochemical localization of Zn-α2-glycoprotein in normal human tissues. J Histochem Cytochem 39:1221-1226
3. Hassan MI, Waheed A, Yadav S, Singh TP, Ahmad F 2008 Zinc α2-glycoprotein: a multidisciplinary protein. Mol Cancer Res 6:892-906
4. Todorov PT, McDevitt TM, Meyer DJ, Ueyama H, Ohkubo I, Tisdale MJ 1998 Purification and characterisation of a tumor lipid-mobilising factor. Cancer Res 58:2353-2358
5. Russell ST, Zimmerman TP, Domin BA, Tisdale MJ 2004 Induction of lipolysis in vitro and loss of body fat in vivo by zinc-α2-glycoprotein. Biochim Biophys Acta 1636:59-68
6. Bing C, Bao Y, Jenkins J, Sanders P, Manieri M, Cinti S, Tisdale MJ, Trayhurn P 2004 Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci USA 101:2500-2505
7. Hirai K, Hussey HJ, Barber MD, Price SA, Tisdale MJ 1998 Biological evaluation of a lipid mobilizing factor isolated from the urine of cancer patients. Cancer Res 58:2359-2365
8. Bao Y, Bing C, Hunter L, Jenkins JR, Wabitsch M, Trayhurn P 2005 Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed and secreted by human (SGBS) adipocytes. FEBS Lett 579:41-47
9. Rolli V, Radosavljevic M, Astier V, Macquin C, Castan-Laurell I, Visentin V, Guigné C, Carpéné C, Valet P, Gilfillan S, Bahram S 2007 Lipolysis is altered in MHC class 1 zinc-α2-glycoprotein deficient mice. FEBS Lett 581:394-400
10. Stejskal D, Karpíŝek M, Reutová H, Stejskal P, Kotolová H, Kollár P 2008 Determination of serum zinc-α2-glycoprotein in patients with metabolic syndrome by a new ELISA. Clin Biochem 41:313-316
11. Marrades MP, Martínez JA, Moreno-Aliaga MJ 2008 ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem 64:61-66
12. 2001 Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285:2486-2497
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC 1985 Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetología 28:412-419
14. World Health Organization 2000 Obesity: preventing and managing the global epidemic. Report of a WHO Consultation Geneva. WHO Technical Report Series 894. 1st ed. Geneva: World Health Organization
15. Gohda T, Makita Y, Shike T, Tanimoto M, Funabiki K, Horikoshi S, Tomino Y 2003 Identification of epistatic interaction involved in obesity using the KK/Ta mouse as a type 2 diabetes model: is Zn-α2 glycoprotein-1 a candidate gene for obesity? Diabetes 52:2175-2181
16. Russell ST, Hirai K, Tisdale MJ 2002 Role of β3-adrenergic receptors in the action of a tumour lipid mobilizing factor. Br J Cancer 86:424-428
17. Margareto J, Larrarte E, Marti A, Martinez JA 2001 Up-regulation of a thermogenesis-related gene (UCP1) and down-regulation of PPARγ and aP2 genes in adipose tissue: possible features of the antiobesity effects of a βa3-adrenergic agonist. Biochem Pharmacol 61:1471-1478
18. López-Boado YS, Diez-Itza I, Tolivia J, López-Otin C 1994 Glucocorticoids and androgens up-regulate the Zn-α2-glycoprotein messenger RNA in human breast cancer cells. Breast Cancer Res Treat 29:247-258
19. Zimmermann R, Strauss JG, Haemmerle G, Schoiswohl G, Birner-Gruenberger R, Riederer M, Lass A, Neuberger G, Eisenhaber F, Hermetter A, Zechner R 2004 Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383-1386
20. Jocken JW, Langin D, Smit E, Saris WH, Valle C, Hul GB, Holm C, Arner P, Blaak EE 2007 Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulinresistant state. J Clin Endocrinol Metab 92:2292-2299
21. Large V, Reynisdottir S, Langin D, Fredby K, Klannemark M, Holm C, Arner P 1999 Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects. J Lipid Res 40:2059-2066
22. Martin LF, Klim CM, Vannucci SJ, Dixon LB, Landis JR, LaNoue KF 1990 Alterations in adipocyte adenylate cyclase activity in morbidly obese and formerly morbidly obese humans. Surgery 108:228-234; discussion 234-235